Cargando…

COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study

BACKGROUND: Although patients recovered from COVID-19 already have immunity gained from natural infection, they are still at risk of reinfection due to the emergence of new variants of COVID-19 and the diminishing of naturally acquired immunity over time. Vaccination is associated with efficacious p...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yiman, Zhang, Ling, Fu, Jiaqi, Wu, Yijin, Wang, Hao, Xiao, Weijun, Xin, You, Dai, Zhenwei, Si, Mingyu, Chen, Xu, Jia, Mengmeng, Leng, Zhiwei, Cui, Dan, Su, Xiaoyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337408/
https://www.ncbi.nlm.nih.gov/pubmed/37247615
http://dx.doi.org/10.2196/42958
_version_ 1785071417248710656
author Huang, Yiman
Zhang, Ling
Fu, Jiaqi
Wu, Yijin
Wang, Hao
Xiao, Weijun
Xin, You
Dai, Zhenwei
Si, Mingyu
Chen, Xu
Jia, Mengmeng
Leng, Zhiwei
Cui, Dan
Su, Xiaoyou
author_facet Huang, Yiman
Zhang, Ling
Fu, Jiaqi
Wu, Yijin
Wang, Hao
Xiao, Weijun
Xin, You
Dai, Zhenwei
Si, Mingyu
Chen, Xu
Jia, Mengmeng
Leng, Zhiwei
Cui, Dan
Su, Xiaoyou
author_sort Huang, Yiman
collection PubMed
description BACKGROUND: Although patients recovered from COVID-19 already have immunity gained from natural infection, they are still at risk of reinfection due to the emergence of new variants of COVID-19 and the diminishing of naturally acquired immunity over time. Vaccination is associated with efficacious protection against COVID-19 infection and could boost infection-acquired immunity; however, various COVID-19 survivors have not been vaccinated due to vaccine hesitancy. OBJECTIVE: The aim of this study was to investigate COVID-19 vaccine hesitancy and related factors among COVID-19 survivors. METHODS: A cross-sectional questionnaire survey was conducted among patients who recovered from COVID-19 infection in Wuhan, China, between June 10 and July 25, 2021. The questionnaire included sociodemographic information, items on COVID-19 infection, the COVID-19 vaccine hesitancy scale based on the 3Cs (complacency, convenience, and confidence) model, trust in vaccine manufacturers and health facilities, and reasons for the decision to accept COVID-19 vaccination. Multivariate logistic regression analysis was used to assess the factors influencing COVID-19 vaccine hesitancy. RESULTS: Among the 1422 participants, 538 (37.8%) were not vaccinated against COVID-19. The COVID-19–recovered patients who self-reported having a current unhealthy status expressed more hesitancy about the COVID-19 vaccine than those who perceived themselves to be healthy (odds ratio [OR] 0.45, 95% CI 0.28-0.71). Compared to the asymptomatic patients, patients with mild symptoms were more likely to receive a COVID-19 vaccine (OR 1.67, 95% CI 1.02-2.82). Regarding the 3Cs model, high complacency (P=.005) and low convenience (P=.004) were significant negative factors for COVID-19 vaccination. Trust in vaccine manufacturers and health facilities was a significant positive factor for COVID-19 vaccination (OR 1.14, 95% CI 1.09-1.19). “Self-needs” was the main reason for patients to receive the COVID-19 vaccine, whereas “already have antibodies and do not need vaccination” was the main reason for patients to not receive the COVID-19 vaccine. CONCLUSIONS: Among the three major factors of vaccine hesitancy, complacency proved to be the most notable among COVID-19–recovered patients. Therefore, educational campaigns can focus on raising the awareness of risk of infection and the benefits of vaccination to reduce complacency toward vaccination among this population. In particular, for individuals who have recovered from COVID-19, improving factors related to convenience such as transportation, the environment of vaccination, and providing door-to-door service was also deemed necessary to facilitate their vaccination. In addition, addressing the concerns about vaccination of COVID-19–recovered patients could foster trust and promote their uptake of vaccination.
format Online
Article
Text
id pubmed-10337408
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-103374082023-07-13 COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study Huang, Yiman Zhang, Ling Fu, Jiaqi Wu, Yijin Wang, Hao Xiao, Weijun Xin, You Dai, Zhenwei Si, Mingyu Chen, Xu Jia, Mengmeng Leng, Zhiwei Cui, Dan Su, Xiaoyou JMIR Public Health Surveill Original Paper BACKGROUND: Although patients recovered from COVID-19 already have immunity gained from natural infection, they are still at risk of reinfection due to the emergence of new variants of COVID-19 and the diminishing of naturally acquired immunity over time. Vaccination is associated with efficacious protection against COVID-19 infection and could boost infection-acquired immunity; however, various COVID-19 survivors have not been vaccinated due to vaccine hesitancy. OBJECTIVE: The aim of this study was to investigate COVID-19 vaccine hesitancy and related factors among COVID-19 survivors. METHODS: A cross-sectional questionnaire survey was conducted among patients who recovered from COVID-19 infection in Wuhan, China, between June 10 and July 25, 2021. The questionnaire included sociodemographic information, items on COVID-19 infection, the COVID-19 vaccine hesitancy scale based on the 3Cs (complacency, convenience, and confidence) model, trust in vaccine manufacturers and health facilities, and reasons for the decision to accept COVID-19 vaccination. Multivariate logistic regression analysis was used to assess the factors influencing COVID-19 vaccine hesitancy. RESULTS: Among the 1422 participants, 538 (37.8%) were not vaccinated against COVID-19. The COVID-19–recovered patients who self-reported having a current unhealthy status expressed more hesitancy about the COVID-19 vaccine than those who perceived themselves to be healthy (odds ratio [OR] 0.45, 95% CI 0.28-0.71). Compared to the asymptomatic patients, patients with mild symptoms were more likely to receive a COVID-19 vaccine (OR 1.67, 95% CI 1.02-2.82). Regarding the 3Cs model, high complacency (P=.005) and low convenience (P=.004) were significant negative factors for COVID-19 vaccination. Trust in vaccine manufacturers and health facilities was a significant positive factor for COVID-19 vaccination (OR 1.14, 95% CI 1.09-1.19). “Self-needs” was the main reason for patients to receive the COVID-19 vaccine, whereas “already have antibodies and do not need vaccination” was the main reason for patients to not receive the COVID-19 vaccine. CONCLUSIONS: Among the three major factors of vaccine hesitancy, complacency proved to be the most notable among COVID-19–recovered patients. Therefore, educational campaigns can focus on raising the awareness of risk of infection and the benefits of vaccination to reduce complacency toward vaccination among this population. In particular, for individuals who have recovered from COVID-19, improving factors related to convenience such as transportation, the environment of vaccination, and providing door-to-door service was also deemed necessary to facilitate their vaccination. In addition, addressing the concerns about vaccination of COVID-19–recovered patients could foster trust and promote their uptake of vaccination. JMIR Publications 2023-07-03 /pmc/articles/PMC10337408/ /pubmed/37247615 http://dx.doi.org/10.2196/42958 Text en ©Yiman Huang, Ling Zhang, Jiaqi Fu, Yijin Wu, Hao Wang, Weijun Xiao, You Xin, Zhenwei Dai, Mingyu Si, Xu Chen, Mengmeng Jia, Zhiwei Leng, Dan Cui, Xiaoyou Su. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 03.07.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Huang, Yiman
Zhang, Ling
Fu, Jiaqi
Wu, Yijin
Wang, Hao
Xiao, Weijun
Xin, You
Dai, Zhenwei
Si, Mingyu
Chen, Xu
Jia, Mengmeng
Leng, Zhiwei
Cui, Dan
Su, Xiaoyou
COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title_full COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title_fullStr COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title_full_unstemmed COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title_short COVID-19 Vaccine Hesitancy Among Patients Recovered From COVID-19 Infection in Wuhan, China: Cross-Sectional Questionnaire Study
title_sort covid-19 vaccine hesitancy among patients recovered from covid-19 infection in wuhan, china: cross-sectional questionnaire study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337408/
https://www.ncbi.nlm.nih.gov/pubmed/37247615
http://dx.doi.org/10.2196/42958
work_keys_str_mv AT huangyiman covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT zhangling covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT fujiaqi covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT wuyijin covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT wanghao covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT xiaoweijun covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT xinyou covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT daizhenwei covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT simingyu covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT chenxu covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT jiamengmeng covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT lengzhiwei covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT cuidan covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy
AT suxiaoyou covid19vaccinehesitancyamongpatientsrecoveredfromcovid19infectioninwuhanchinacrosssectionalquestionnairestudy